Concepedia

Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy

Francesco Semeraro, Anna Cancarini, Francesco Morescalchi, Mario R. Romano, Roberto dell’Omo, Giuseppina Ruggeri, Luca Agnifili, Ciro Costagliola

Diabetes & Metabolism · 2014 · 44 citations · 32 references

DOI

Concepts

References

32

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

Lloyd Paul Aiello, Robert L. Avery, Paul G. Arrigg et al. · New England Journal of Medicine · 1994 · 3.8K citations · Full text

, , +15

Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans

Katherine Esposito, Francesco Nappo, Raffaele Marfella et al. · Circulation · 2002 · 2K citations

, , +17

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Lloyd Paul Aiello, Eric A. Pierce, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1.3K citations · Full text

, , +16

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy

Robert L. Avery, Joel Pearlman, Dante J. Pieramici et al. · Ophthalmology · 2006 · 802 citations

, , +13

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

Christian Grimm, Andreas Wenzel, Matthias Groszer et al. · Nature Medicine · 2002 · 522 citations

, , +16